Month: May 2020

BEIJING, CHINA, May 08, 2020 (GLOBE NEWSWIRE) — China Liberal Education Holdings Limited (Nasdaq: CLEU) (“China Liberal”), an educational services provider in China, today announced that its ordinary shares have commenced trading on The Nasdaq Capital Market under the ticker symbol “CLEU”.China Liberal priced its initial public offering (“IPO”) of 1,333,333 ordinary shares at $6.00 per ordinary share, before underwriting discounts and offering expenses, resulting in gross proceeds of $8,000,000. The offering was conducted on a firm commitment basis and is expected to close on May 12, 2020, subject to customary closing conditions.Boustead Securities, LLC (“Boustead”), acted as the sole underwriter for the offering, with Zinvest Global Limited in Hong Kong serving as Asian book runner. Hunter Taubman Fischer & Li LLC acted as counsel...

BRIDGEWATER, N.J., May 08, 2020 (GLOBE NEWSWIRE) — Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated biopharmaceutical company, today announced that the Company will release its 2020 first quarter financial results on Tuesday, May 12, 2020, after the close of the U.S. financial markets.Brian Markison, Chief Executive Officer, James “JD” Schaub, Chief Operating Officer, and Andrew Einhorn, Chief Financial Officer, will host a conference call as follows:About Osmotica Pharmaceuticals plcOsmotica Pharmaceuticals plc is a fully integrated biopharmaceutical company focused on the development and commercialization of specialty products that target markets with underserved patient populations. Vertical Pharmaceuticals, LLC represents the Company’s diversified branded portfolio and Trigen Laboratories,...

Sudbury, Ontario, May 08, 2020 (GLOBE NEWSWIRE) — On April 3, the Vale COVID-19 challenge was launched in Canada to help propel innovative COVID-19 solutions developed by companies, startups, institutions, universities or professionals into the marketplace by offering financial support of up to USD $1M.A total of nearly 1,800 solutions were submitted globally, of which over 300 came from within Canada. All solutions were carefully reviewed by a select group of employees as well as external partners and supporters, which, in Canada, included:Mater Dei Hospital in Brazil,Dr. Ken Jenkins (Horizon supported by TELUS Health),Dr. Farrell Cahill (Medisys supported by TELUS Health),Dr. Greg Ross (Health Sciences North Sudbury),Don Duval (NORCAT),Dr. Shahid Husain (University Health Network)Sheryl Thingvold (MaRS Discovery District).“The participation...

Hoivatilat PlcStock exchange release8 May 2020 at 7.50 pm EESTArbitral tribunal has confirmed Aureit Holding Oy’s redemption right regarding Hoivatilat’s minority shares and trading in Hoivatilat’s shares will be suspendedThe arbitral tribunal appointed by the Redemption Board of the Finland Chamber of Commerce has today confirmed that Aureit Holding Oy (“Aureit Holding”) has the right to redeem the minority shares in Hoivatilat Plc (“Hoivatilat”) and that Aureit Holding has the right to obtain title to the minority shares by posting a security approved by the arbitral tribunal for the payment of the redemption price and the interest accruing thereon.Following Hoivatilat’s application, Nasdaq Helsinki Ltd (“Nasdaq Helsinki”) has on 23 April 2020 confirmed that that the quotation...

Hoivatilat OyjPörssitiedote8.5.2020 klo 19:50 EESTVälimiesoikeus on vahvistanut Aureit Holding Oy:n lunastusoikeuden Hoivatilojen vähemmistöosakkeisiin ja kaupankäynti Hoivatilojen osakkeilla keskeytetäänKeskuskauppakamarin lunastuslautakunnan nimittämä välimiesoikeus on tänään vahvistanut, että Aureit Holding Oy:llä (“Aureit Holding”) on oikeus lunastaa Hoivatilat Oyj:n (“Hoivatilat”) vähemmistöosakkeet ja että Aureit Holdingilla on oikeus saada vähemmistöosakkeet omistukseensa asettamalla lunastushinnan ja sille kertyvän koron maksamisesta välimiesoikeuden hyväksymä vakuus.Nasdaq Helsinki Oy (“Nasdaq Helsinki”) on 23.4.2020 Hoivatilojen hakemuksen johdosta vahvistanut, että Hoivatilojen osakkeiden noteeraus Nasdaq Helsingin pörssilistalla päättyy mahdollisimman pian sen jälkeen, kun Aureit Holding...

TRYbeCA-1 Phase-III-Studie:Mehr als 75 % der ca. 500 geplanten Patienten wurden bereits aufgenommenFast-Track-Status von US-amerikanischer FDA zuerkanntStudie soll wie geplant nach dritter unabhängiger Sicherheitsüberprüfung fortgesetzt werdenDie Interims-Überlegenheitsanalyse wird zum Jahresende erwartet und die abschließende Analyse in der zweiten Jahreshälfte 2021Barposition in Höhe von 58,6 Millionen Euro (64,6 Millionen US-Dollar) am Ende des ersten Quartals 2020LYON, Frankreich und CAMBRIDGE, Mass., May 08, 2020 (GLOBE NEWSWIRE) — ERYTECH Pharma (Nasdaq und Euronext: ERYP), ein biopharmazeutisches Unternehmen im Bereich der klinischen Forschung, das innovative Therapien entwickelt, bei denen Arzneimittelwirkstoffe in roten Blutkörperchen eingekapselt werden, gab heute ein Update zum Unternehmen und der Finanzlage.„In den vergangenen...

Studio di fase 3 TRYbeCA-1:Più del 75% dei circa 500 pazienti previsti è stato arruolatoDesignazione Fast-Track concessa dalla FDA statunitenseLo studio continuerà come previsto dopo la terza valutazione indipendente sulla sicurezzaAnalisi di superiorità ad interim prevista intorno alla fine dell’anno e analisi finale nel secondo semestre del 2021Posizione finanziaria di €58,6 milioni ($64,6 milioni) alla fine del primo trimestre 2020LIONE, Francia, e CAMBRIDGE, Mass., May 08, 2020 (GLOBE NEWSWIRE) — ERYTECH Pharma (Nasdaq & Euronext: ERYP), un’azienda biofarmaceutica in fase clinica che sviluppa terapie innovative incapsulando sostanze farmacologiche all’interno dei globuli rossi, ha presentato oggi un aggiornamento sulle attività della società e sui suoi dati finanziari.“In queste ultime settimane della pandemia di COVID-19,...

VALCOURT, Quebec, May 08, 2020 (GLOBE NEWSWIRE) — BRP (TSX:DOO; NASDAQ:DOOO) announced today that it has entered into an incremental US$600 million term loan maturing in May 2027, further bolstering the Company’s liquidity position.“We have always been diligent in safeguarding the Company’s financial flexibility, and this incremental term loan is another example of this. With our strong cash position coupled with the CA$700 million available under our revolving credit facility, we expect to have the capacity to navigate through these uncertain times while continuing to invest for the long-term growth of the Company,” said Sébastien Martel, Chief Financial Officer of BRP.Following the completion of this transaction and after reimbursing its fully drawn revolving credit facility, the Company will have approximately CA$680 million of...

VALCOURT, Québec, 08 mai 2020 (GLOBE NEWSWIRE) — BRP (TSX: DOO; NASDAQ: DOOO) a annoncé aujourd’hui avoir conclu un prêt à terme supplémentaire de 600 millions de dollars américains qui arrive à échéance en mai 2027, renforçant la position de liquidité de la Société.« Nous avons toujours fait preuve de diligence pour préserver la flexibilité financière de la Société, et ce prêt à terme supplémentaire en est un autre exemple. Grâce à notre solide position financière ainsi qu’aux 700 millions de dollars canadiens disponibles dans le cadre de notre facilité de crédit renouvelable, nous prévoyons avoir la capacité de naviguer à travers ces temps incertains tout en continuant d’investir pour la croissance à long terme de la Société », a déclaré Sébastien Martel, chef de la direction financière.Suivant la conclusion de cette transaction...